McMillan Office, Inc.

Source: SEC Form 13F · as of Mar 2026

McMillan Office, Inc. holds 31 biotech & pharma companies tracked by BioSniper, totaling $67.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

31

Total value held

$67.1M

CompanySharesValue
ABBVAbbVie Inc.78,743$17.1M
JNJJOHNSON & JOHNSON49,267$12.0M
PFEPFIZER INC350,593$9.8M
ABTABBOTT LABORATORIES48,781$5.0M
BMYBRISTOL MYERS SQUIBB CO80,193$4.9M
NVONovo Nordisk A/S107,554$4.0M
MRKMerck & Co., Inc.31,970$3.8M
LLYELI LILLY & Co3,554$3.3M
AMGNAMGEN INC5,530$1.9M
ZBHZimmer Biomet Holdings Inc.8,687$786K
CAHCardinal Health Inc.3,073$649K
VTRSViatris Inc41,370$559K
GEHCGE HealthCare Technologies Inc.7,828$557K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)7,241$400K
TEVATeva Pharmaceutical Industries Limited12,675$382K
GILDGILEAD SCIENCES, INC.2,540$354K
LCTXLineage Cell Therapeutics, Inc.216,000$341K
UNHUnitedHealth Group Incorporated Common Stock (DE)1,000$271K
BIIBBIOGEN INC.1,150$211K
NVSNovartis AG1,068$163K
VRTXVERTEX PHARMACEUTICALS INC / MA300$134K
AZNASTRAZENECA PLC616$121K
DGXQuest Diagnostics Incorporated486$95K
PMPhilip Morris International Inc310$51K
BAXBaxter International Inc.2,800$47K
SNYSanofi500$24K
AVNSAvanos Medical Inc.701$10K
OGNOrganon & Co.1,250$7K
IDXXIDEXX LABORATORIES INC /DE4$2K
BHCBausch Health Companies Inc.300$2K
GMOptec International, Inc.16$1K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    McMillan Office, Inc. — Biotech 13F Holdings & Portfolio | BioSniper